Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology
- PMID: 19166507
- DOI: 10.1111/j.1471-4159.2009.05919.x
Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology
Abstract
In this work we showed that genotype-related patterns of hexosaminidase activity, isoenzyme composition, gene expression and ganglioside metabolism observed during embryonic and postnatal brain development are recapitulated during the progressive stages of neural precursor cell (NPC) differentiation to mature glia and neurons in vitro. Further, by comparing NPCs and their differentiated progeny established from Tay-Sachs (TS) and Sandhoff (SD) animal models with the wild-type counterparts, we studied the events linking the accumulation of undegraded substrates to hexosaminidase activity. We showed that similarly to what observed in brain tissues in TS NPCs and progeny, the stored GM2 was partially converted by sialidase to GA2, which can be then degraded in the lysosomes to its components. The latter can be used in a salvage pathway for the formation of GM3. Interestingly, results obtained from ganglioside feeding assays and from measurement of lysosomal sialidase activity suggest that a similar pathway might work also in the SD model.
Similar articles
-
[Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].Yakugaku Zasshi. 2013;133(2):269-74. doi: 10.1248/yakushi.12-00199. Yakugaku Zasshi. 2013. PMID: 23370522 Review. Japanese.
-
Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.Exp Neurol. 2018 Jan;299(Pt A):26-41. doi: 10.1016/j.expneurol.2017.09.012. Epub 2017 Sep 30. Exp Neurol. 2018. PMID: 28974375
-
Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis.Neurobiol Dis. 2020 Feb;134:104667. doi: 10.1016/j.nbd.2019.104667. Epub 2019 Nov 1. Neurobiol Dis. 2020. PMID: 31682993
-
Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.Neuroreport. 2003 Mar 24;14(4):551-4. doi: 10.1097/00001756-200303240-00004. Neuroreport. 2003. PMID: 12657883
-
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.Pediatrics. 2006 Nov;118(5):e1550-62. doi: 10.1542/peds.2006-0588. Epub 2006 Oct 2. Pediatrics. 2006. PMID: 17015493 Free PMC article. Review.
Cited by
-
Above the Epitranscriptome: RNA Modifications and Stem Cell Identity.Genes (Basel). 2018 Jun 28;9(7):329. doi: 10.3390/genes9070329. Genes (Basel). 2018. PMID: 29958477 Free PMC article. Review.
-
Unpatterned Bioactive Poly(Butylene 1,4-Cyclohexanedicarboxylate)-Based Film Fast Induced Neuronal-Like Differentiation of Human Bone Marrow-Mesenchymal Stem Cells.Int J Mol Sci. 2020 Dec 4;21(23):9274. doi: 10.3390/ijms21239274. Int J Mol Sci. 2020. PMID: 33291757 Free PMC article.
-
Nanocomposites Based on Biodegradable Polymers.Materials (Basel). 2018 May 15;11(5):795. doi: 10.3390/ma11050795. Materials (Basel). 2018. PMID: 29762482 Free PMC article. Review.
-
Mice doubly-deficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss.PLoS Genet. 2010 Sep 16;6(9):e1001118. doi: 10.1371/journal.pgen.1001118. PLoS Genet. 2010. PMID: 20862357 Free PMC article.
-
Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes.Mol Neurobiol. 2015 Aug;52(1):610-25. doi: 10.1007/s12035-014-8883-6. Epub 2014 Sep 23. Mol Neurobiol. 2015. PMID: 25241647 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases